Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$2.03B |
 |
Edwards LifesciencesEW |
-$364M |
 |
Intuitive SurgicalISRG |
-$1.36B |
 |
GE HealthCareGEHC |
-$18M |
 |
MedpaceMEDP |
-$66.9B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Smith Gregory L | Nov 19, 2025 | Sell | 1,942 | $101.99 | $200,000 |
| Smith Gregory L | Nov 19, 2025 | Sell | 1,995 | $102.03 | $200,000 |
| Smith Gregory L | Nov 19, 2025 | Sell | 227 | $102.05 | $23,000 |
| Smith Gregory L | Nov 19, 2025 | Sell | 24,186 | $101.93 | $2.5M |
| Smith Gregory L | Nov 19, 2025 | Sell | 325 | $102.06 | $33,000 |
| Smith Gregory L | Nov 19, 2025 | Sell | 500 | $102.08 | $51,000 |
| Smith Gregory L | Nov 19, 2025 | Sell | 825 | $102.04 | $84,000 |
| KIIL HARRY SKIP | Sep 3, 2025 | Sell | 200 | $91.59 | $18,000 |
| KIIL HARRY SKIP | Sep 3, 2025 | Sell | 8,405 | $91.58 | $770,000 |
| Jellison William R | Aug 25, 2025 | Buy | 2,500 | $92.37 | $230,000 |
| Wall Brett A. | Jan 24, 2025 | Sell | 12,437 | $90 | $1.1M |
| Wall Brett A. | Jan 8, 2025 | Sell | 3,000 | $80.41 | $240,000 |
| Wall Brett A. | Jan 8, 2025 | Sell | 6,850 | $80.41 | $550,000 |
| Martha Geoffrey | Jun 7, 2024 | Sell | 1,594 | $83.82 | $130,000 |
| Martha Geoffrey | Jun 7, 2024 | Sell | 17,519 | $83.76 | $1.5M |
| Marinaro Michael | Apr 8, 2024 | Sell | 854 | $83.14 | $71,000 |
| Salmon Sean | Feb 21, 2024 | Sell | 16,035 | $85.12 | $1.4M |
| Salmon Sean | Feb 21, 2024 | Sell | 1,594 | $85.06 | $140,000 |
| Salmon Sean | Feb 21, 2024 | Sell | 13,066 | $85.15 | $1.1M |
FAQ - Insider Transactions
The most recent insider transaction for Medtronic was conducted by Smith Gregory L, who sold 1,942 shares on November 19, 2025 at a price of $101.99 per share.
Jellison William R has bought the most MDT stock in the last 2 years, with a total value of $230,000.
Smith Gregory L has sold the most MDT stock in the last 2 years, with a total value of $3.1M.
The total value of insider transactions for Medtronic in the last 2 years is negative, amounting to -$9.8M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Medtronic have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
